Achieve Life Sciences, Inc.
ACHV
$5.10
$0.255.16%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 33.26M | 31.88M | 25.92M | 21.40M | 18.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.45M | 54.88M | 52.34M | 50.11M | 45.98M |
| Operating Income | -52.45M | -54.88M | -52.34M | -50.11M | -45.98M |
| Income Before Tax | -51.99M | -54.65M | -52.35M | -50.42M | -46.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -51.99 | -54.65 | -52.35 | -50.42 | -46.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.99M | -54.65M | -52.35M | -50.42M | -46.16M |
| EBIT | -52.45M | -54.88M | -52.34M | -50.11M | -45.98M |
| EBITDA | -52.23M | -54.65M | -52.11M | -49.88M | -45.75M |
| EPS Basic | -1.12 | -1.29 | -1.38 | -1.46 | -1.34 |
| Normalized Basic EPS | -0.70 | -0.80 | -0.85 | -0.89 | -0.82 |
| EPS Diluted | -1.12 | -1.29 | -1.38 | -1.46 | -1.34 |
| Normalized Diluted EPS | -0.70 | -0.80 | -0.85 | -0.89 | -0.82 |
| Average Basic Shares Outstanding | 192.36M | 173.66M | 154.90M | 138.24M | 137.87M |
| Average Diluted Shares Outstanding | 192.36M | 173.66M | 154.90M | 138.24M | 137.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |